<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR940705-2-00154</title>
	</head>
	<body>
		<main>
			<p><!-- PJG STAG 4703 -->  <!-- PJG ITAG l=11 g=1 f=1 --> Appendix Q-II-C&hyph;1-g-(2). Appropriate steps should be taken to prevent horizontal  <!-- PJG 0012 frnewline --> transmission or exposure of laboratory personnel. If the agent used as the vector is  <!-- PJG 0012 frnewline --> known to be transmitted by a particular route (e.g., arthropods), special attention  <!-- PJG 0012 frnewline --> should be given to preventing spread by that route. In the absence of specific  <!-- PJG 0012 frnewline --> knowledge of a particular route of transmission, all potential means of horizontal  <!-- PJG 0012 frnewline --> transmission (e.g., arthropods, contaminated bedding, or animal waste) should be  <!-- PJG 0012 frnewline --> prevented.  <!-- PJG 0012 frnewline --> Appendix Q-II-C&hyph;1-g-(3). Eating, drinking, smoking, and applying cosmetics shall  <!-- PJG 0012 frnewline --> not be permitted in the work area.  <!-- PJG 0012 frnewline --> Appendix Q-II-C&hyph;1-g-(4). Individuals who handle materials and animals  <!-- PJG 0012 frnewline --> containing recombinant DNA molecules shall be required to wash their hands  <!-- PJG 0012 frnewline --> before exiting the containment area.  <!-- PJG 0012 frnewline --> Appendix Q-II-C&hyph;1-g-(5). Experiments involving other organisms that require  <!-- PJG 0012 frnewline --> containment levels lower than BL3&hyph;N may be conducted in the same area  <!-- PJG 0012 frnewline --> concurrently with experiments requiring BL3&hyph;N containment provided that they are  <!-- PJG 0012 frnewline --> conducted in accordance with BL3&hyph;N practices.  <!-- PJG 0012 frnewline --> Appendix Q-II-C&hyph;1-g-(6). Animal holding areas shall be cleaned at least once a  <!-- PJG 0012 frnewline --> day and decontaminated immediately following any spill of viable materials.  <!-- PJG 0012 frnewline --> Appendix Q-II-C&hyph;1-g-(7). All procedures shall be performed carefully to minimize  <!-- PJG 0012 frnewline --> the creation of aerosols.  <!-- PJG 0012 frnewline --> Appendix Q-II-C&hyph;1-g-(8). A double barrier shall be provided to separate male and  <!-- PJG 0012 frnewline --> female animals unless reproductive studies are part of the experiment or other  <!-- PJG 0012 frnewline --> measures are taken to avoid reproductive transmission. Reproductive  <!-- PJG 0012 frnewline --> incapacitation may be used.  <!-- PJG 0012 frnewline --> Appendix Q-II-C&hyph;1-g-(9). The containment area shall be in accordance with state  <!-- PJG 0012 frnewline --> and Federal laws and animal care requirements.  <!-- PJG 0012 frnewline --> Appendix Q-II-C&hyph;1-g-(10). All animals shall be euthanized at the end of their  <!-- PJG 0012 frnewline --> experimental usefulness and the carcasses decontaminated before disposal in an  <!-- PJG 0012 frnewline --> approved manner.  <!-- PJG 0012 frnewline --> Appendix Q-II-C&hyph;1-g-(11). Personnel shall be required to shower before exiting  <!-- PJG 0012 frnewline --> the BL3&hyph;N area and wearing personal clothing.  <!-- PJG 0012 frnewline --> Appendix Q-II-C&hyph;1-g-(12). Animals of the same or different species, which are not  <!-- PJG 0012 frnewline --> involved in the work being performed, shall not be permitted in the animal area.  <!-- PJG 0012 frnewline --> Appendix Q-II-C&hyph;1-g-(13). Needles and syringes shall be used only for parenteral  <!-- PJG 0012 frnewline --> injection and aspiration of fluids from laboratory animals and diaphragm bottles.  <!-- PJG 0012 frnewline --> Only needle-locking syringes or disposable syringe-needle units (i.e., needle is  <!-- PJG 0012 frnewline --> integral to the syringe) shall be used for the injection or aspiration of fluids  <!-- PJG 0012 frnewline --> containing organisms that contain recombinant DNA. Extreme caution shall be  <!-- PJG 0012 frnewline --> used when handling needles and syringes to avoid autoinoculation and the  <!-- PJG 0012 frnewline --> generation of aerosols during use and disposal. Following use, needles shall not be  <!-- PJG 0012 frnewline --> bent, sheared, replaced in the needle sheath or guard or removed from the syringe.  <!-- PJG 0012 frnewline --> The needles and syringes shall be promptly placed in a puncture-resistant container  <!-- PJG 0012 frnewline --> and decontaminated, preferably by autoclaving, before discard or reuse.  <!-- PJG 0012 frnewline --> Appendix Q-II-C&hyph;1-g-(14). A biosafety manual shall be prepared or adopted.  <!-- PJG 0012 frnewline --> Personnel shall be advised of special hazards and required to read and follow  <!-- PJG 0012 frnewline --> instructions on practices and procedures.  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=81 g=1 f=1 --> Appendix Q-II-C&hyph;2. Animal Facilities (BL3&hyph;N)  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> Appendix Q-II-C&hyph;2-a. Animals shall be contained within an enclosed structure  <!-- PJG 0012 frnewline --> (animal room or equivalent) to minimize the possibility of theft or unintentional  <!-- PJG 0012 frnewline --> release and avoid arthropod access. The special provision to avoid the entry or  <!-- PJG 0012 frnewline --> escape of arthropods from the animal areas may be waived if the agent in use is  <!-- PJG 0012 frnewline --> not known to be transmitted by arthropods.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG /STAG --></p>
		</main>
</body></html>
            